cycloleucine has been researched along with Learning Disabilities in 1 studies
Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, YM | 1 |
| Jia, Z | 1 |
| Janus, C | 1 |
| Henderson, JT | 1 |
| Gerlai, R | 1 |
| Wojtowicz, JM | 1 |
| Roder, JC | 1 |
1 other study available for cycloleucine and Learning Disabilities
| Article | Year |
|---|---|
Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.
Topics: Animals; Behavior, Animal; Binding, Competitive; Central Nervous System; Conditioning, Psychological | 1997 |